Today: 3 June 2026
Dow Jones Live Update: Blue-Chip Index Turns Higher as Oil Spike Tests Stock Market Rally
11 May 2026
2 mins read

Dow Jones Live Update: Blue-Chip Index Turns Higher as Oil Spike Tests Stock Market Rally

New York, May 11, 2026, 11:06 EDT

  • The Dow Jones Industrial Average nudged upward as late-morning trading rolled on.
  • S&P 500 and Nasdaq held onto gains, trading in the green after last week’s record finishes.
  • Oil’s surge yanks Tuesday’s consumer inflation report right back into focus.

The Dow Jones Industrial Average edged up by 85.76 points, or 0.17%, to 49,694.92 late Monday morning, shrugging off another uptick in oil prices. The S&P 500 was up 0.23% at 7,416.00. Nasdaq Composite tacked on 0.12%, landing at 26,277.35, LSEG figures showed via Reuters.

It’s a tough spot for Wall Street as a record rally faces fresh tests: on one side, robust corporate earnings; on the other, a spike in anxiety over U.S.-Iran tensions. Crude jumped nearly 3% early Monday, according to Reuters, after President Donald Trump turned down Iran’s answer to a U.S. peace offer, fueling concern that Strait of Hormuz shipping lanes might remain frozen.

The Dow barely budged, trailing behind the sharper climbs seen in the S&P 500 and Nasdaq, but managed to hold close to where it finished last week. Both the S&P 500 and Nasdaq wrapped up Friday at record highs, driven by AI-centric names and an unexpectedly robust April jobs readout. The Dow, for its part, inched up just 0.02% on the day—good enough for a second weekly advance in a row.

“The worry list is long, but the economy keeps proving the bears wrong,” Robert Edwards, chief investment officer at Edwards Asset Management, told Reuters. Solid revenue and earnings growth have put big tech back at the front, he said, pointing to their renewed leadership. Reuters

Energy names stood out. Brent crude pushed up 2.63% to $103.95. The U.S. 10-year Treasury yield also climbed, reaching 4.386%—a shift that tends to raise borrowing costs across the board and tighten financial conditions.

The Dow tracks 30 major U.S. blue chips, weighted by price—so pricier stocks move the needle more than cheaper ones. Its trajectory doesn’t match the S&P 500 or Nasdaq, both of which have ridden the surge in megacap tech and semiconductor names.

Individual names reflected the broader divergence. Intel climbed, Reuters said, extending Friday’s gains after word of an early-stage chip-supply pact with Apple. Qualcomm notched a record high. On the flip side, airlines like Southwest, Delta, Alaska Air, and United slumped, squeezed by rising fuel expenses cutting into margins.

Inflation is up next. The consumer price index lands Tuesday, and economists in a Reuters poll see a 0.6% climb for April. Core CPI—excluding those unpredictable energy prices—could have a bigger impact on what traders expect from the Federal Reserve on rates.

Still, there’s a chance oil pushes prices up beyond what markets are betting on. “If core CPI is significantly higher, I think that’s going to be very problematic,” Kristina Hooper, chief market strategist at Man Group, told Reuters. Reuters

The Dow isn’t driving the action right now—it’s just holding on. Broader moves hinge on earnings updates, the appetite for AI, and the question of oil sticking at levels that could muddy things for the Fed.

Latest articles

Snap Lags Nasdaq, Turnaround Pressure Rises

Snap Lags Nasdaq, Turnaround Pressure Rises

3 June 2026
Snap Inc. shares slid 1.5% to $5.76 Tuesday—about 45% below last July’s high—even as the broader market rose, spotlighting investor doubts about Snap’s turnaround despite first-quarter revenue growth, narrowed losses, and major cost cuts; ad growth remains sluggish and the upcoming Specs update on June 16 is seen as a key test for future revenue momentum.
INFQ back on radar after UK quantum push; shares jump

INFQ back on radar after UK quantum push; shares jump

3 June 2026
Infleqtion shares surged 12.4% to $19.87 in late New York trading after announcing Gold Sponsorship of Quantum Fringe 2026 and new U.K. quantum partnerships, as investors bet on government contracts and expanded manufacturing, despite a $30.3 million quarterly net loss and warnings of ongoing operating losses if public-sector funding slows.
Corning shares move after AI news

Corning shares move after AI news

3 June 2026
Corning soared 13.4% to $200.40 on heavy volume after Nvidia’s CEO spotlighted the need for optical links in AI data centers, with Corning’s recent Nvidia and Meta deals making it a top play on AI infrastructure; first-quarter core sales jumped 18% and optical sales surged 36%, but investors face risks from consumer electronics demand and execution on new factory expansions.
Quantum computing stocks face a holiday week after IonQ stake filing and a Rigetti downgrade

IonQ Stock Jumped Again. A Giant Quantum IPO Is Putting the Trade on Trial

3 June 2026
IonQ shares closed up 3.1% at $71.40 before slipping 1.3% after hours as traders positioned ahead of Quantinuum’s upsized IPO, which seeks up to $1.46 billion at a $14.3 billion valuation; IonQ’s Q1 revenue surged 755% to $64.7 million with a raised 2026 outlook, but a $271.5 million operating loss and guidance for continued high expenses highlight risks as Wall Street awaits new sector benchmarks.
Xos Surges After Hours as Data-Center Power Play Hits Tape

Xos Surges After Hours as Data-Center Power Play Hits Tape

3 June 2026
Xos shares soared 135.8% to $5.26 in after-hours trading after launching a 2.5MWh Power Hub for data centers facing grid delays, but the company warned of "substantial doubt" about its ability to continue as a going concern, with just $9.8 million in cash at March 31 and no large orders yet announced for the new product.
Stock Market Today: S&P 500, Nasdaq Hit Fresh Records as Oil Spike Tests Wall Street Rally
Previous Story

Stock Market Today: S&P 500, Nasdaq Hit Fresh Records as Oil Spike Tests Wall Street Rally

Pfizer Stock Rebound Bet: Why the Beaten-Down Healthcare Giant Is Back in Focus
Next Story

Pfizer Stock Rebound Bet: Why the Beaten-Down Healthcare Giant Is Back in Focus

Go toTop